XML 16 R6.htm IDEA: XBRL DOCUMENT v3.4.0.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)
$ in Thousands
3 Months Ended
Apr. 30, 2016
May. 02, 2015
Cash flows from operating activities:    
Net income (loss) $ 1,256 $ (29)
Adjustments to reconcile net income (loss) to net cash flows from operating    
Depreciation and amortization 11,563 10,883
Net (gain) loss on asset disposition 40 (43)
Provision for store closures and asset impairment 77 315
Stock-based compensation 754 219
Provision for uncollectible receivables (265) 344
LIFO reserve increase 930 404
Deferred income tax benefit (1,380) (160)
Income tax charge upon exercise of stock options 9 (214)
(Increase) decrease in operating assets:    
Trade and non-trade receivables 5 (22,491)
Insurance receivables 225 (189)
Inventories (10,758) (11,177)
Other assets 76 1,247
Increase (decrease) in operating liabilities:    
Accounts payable and accrued expenses 3,953 791
Income taxes payable 1,749 12,143
Other noncurrent liabilities (1,377) (1,678)
Net cash provided by (used in) operating activities 6,857 (9,635)
Cash flows provided by (used in) investing activities:    
Capital expenditures (4,609) (5,566)
Proceeds from asset dispositions 15 $ 110
Insurance recoveries for replacement assets 263
Asset acquisition, net (primarily intangibles) $ (3,700) $ (2,793)
Acquisition of Reeves-Sain Drug Store, Inc., net of cash (42,805)
Net cash used in investing activities $ (8,031) (51,054)
Cash flows provided by (used in) financing activities:    
Payments of indebtedness and capital lease obligations (579) (489)
Proceeds from revolving line of credit 222,402 248,012
Payments on revolving line of credit (217,657) (185,685)
Debt issuance (costs) amortization 26 (430)
Excess tax charges (benefit) from stock-based compensation (9) 214
Proceeds from exercise of stock options and employee stock purchase plan 75 1,965
Cash dividends paid (2,233) (2,219)
Net cash provided by financing activities 2,025 61,368
Increase in cash and cash equivalents 851 679
Cash and cash equivalents:    
Beginning of year 5,917 6,440
End of period 6,768 7,119
Supplemental disclosures of cash flow information:    
Interest paid 515 262
Income taxes paid $ 518 144
Non-cash investing and financial activities:    
Acquisition related note payable, see Note 11 - Business Combinations $ 13,000